glp-1 colorectal cancer risk study november 2025 receptor agonists show anti-cancer benefits beyond weight loss GLP-1 drugs linked to major

duodenal mucosal resurfacing) to reverse damage to intestinal nutrient sensing and signaling mechanisms caused by chronic high-fat and high-sugar diets that are a root cause of metabolic disease

For peace of mind

Waist circumference (WC) was measured midway between the costal margin and iliac crests

Our previous study revealed that lenvatinib treatment reduced carnitine content and the expression of carnitine-related and oxidative phosphorylation (OXPHOS) proteins in the skeletal muscle of rats

They can also cause skin aging and increase the risk of skin cancer to develop

Visit our Weight Loss Page to learn more about our consultation services and methods